Photo: IoaBal/Adobe StockA team of United Kingdom investigators will study oronasal mucosal melanoma (OMM) for the benefit of canines and humans. The product is funded with £250,000— about $342,300 USD—in support from donations to the Humanimal Trust’s Cancer Discovery Fund.1,2OMM is the most common oral cancer in canines, yet this aggressive neoplasm is rare in humans. However, there are similarities in biology, clinical presentation and histopathological features between the canine disease and human OMM.3Dogs with OMM survive less than a year, on average, according to the Humanimal Trust. Approximately 1 in 4 dogs, 1 in 3 cats, and as many as 1 in 2 humans will develop cancer during their lifetime. By breaking down the barriers between human and veterinary medicine, we can speed up progress for everyone—creating a future where no life is left behind,” Fitzpatrick said in a news release.1References